Lee R Leddy M.D., MSCR

Accepting New Patients

Accepting New Patients

Provider Image
  • Associate Professor
Degree M.D., MSCR
School University of Florida College of Medicine; Medical University of South Carolina College of Graduate Studies
  • Emory University
  • Emory University
  • Orthopaedics
  • Cancer - Sarcoma
Accepts New Patients Yes
To request an appointment call our representatives at 843-792-1414


Rutledge Tower
135 Rutledge Avenue
Charleston, SC 29425
Map & Directions
MUSC Health Orthopaedics - Columbia
Two Medical Park Drive
Columbia, SC 29203
Map & Directions
MUSC Health at Lowcountry Medical Group
300 Midtown Drive
Beaufort, SC 29906
Map & Directions


Dr. Leddy did his undergraduate work at Emory University where he received his BS in Biological Science while lettering on the varsity basketball team.   He then received his M.D. from the University of Florida College of Medicine in Gainesville, FL.  Dr. Leddy went back to Emory University to complete his internship and residency in the Department of Orthopaedic Surgery.   He now joins us after completing a fellowship in Orthopaedic Oncology at Emory University.    

In Spring 2009, the Medical University of South Carolina Hollings Cancer Center was named a designated cancer center by the National Cancer Institute (NCI). This makes the Hollings Cancer Center South Carolina's only NCI-designated cancer center -- and one of only 65 in the country.  Being an NCI-designated cancer center means we bring together the best research, clinical trials, and new therapies to our patients. After all, the answers to cancer's complex questions are pursued in the labs first and then delivered to patients.  The Department of Orthopaedic Surgery plays a role in the care of bone and soft tissue cancer with the recruitment of a new Orthopaedic Oncologist, Lee R. Leddy, M.D.

As a member of the MUSC Department Orthopaedic Surgery, Dr. Leddy’s primary focus will be providing excellent care to patients with benign and malignant bone and soft tissues tumors, metastatic bone cancer, and osteomyelitis in children and adults.